Entropy Neurodynamics Ltd (ENP)

Currency in AUD
0.037
+0.004(+12.12%)
Closed·
Unusual trading volume
Earnings results expected in 0 days
ENP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.0320.037
52 wk Range
0.0270.046
Key Statistics
Bid/Ask
0.034 / 0.037
Prev. Close
0.037
Open
0.033
Day's Range
0.032-0.037
52 wk Range
0.027-0.046
Volume
5.28M
Average Volume (3m)
2.21M
1-Year Change
-5.1282%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ENP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Entropy Neurodynamics Ltd Company Profile

Entropy Neurodynamics Limited, a clinical-stage pharmaceutical development company, focuses on developing formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs in Australia, Canada, Switzerland, and the United States. The company’s lead program candidate is TRP-8803, a formulation of IV-infused psilocin that completed Phase 2 clinical trial for the treatment of binge eating disorder, fibromyalgia, irritable bowel syndrome, abdominal pain, and visceral tenderness. It is also involved in the development of TRP-8802, a synthetic and oral psilocybin currently under phase 2a clinical trial for the treatment of binge eating, as well as under phase 2 clinical stage for the treatment of fibromyalgia and irritable bowel syndrome. The company was formerly known as Tryptamine Therapeutics Limited and changed its name to Entropy Neurodynamics Limited in November 2025. Entropy Neurodynamics Limited was founded in 2019 and is based in Camberwell, Australia.

Compare ENP to Peers and Sector

Metrics to compare
ENP
Peers
Sector
Relationship
P/E Ratio
−11.2x−12.2x−0.6x
PEG Ratio
−0.15−0.060.00
Price/Book
10.0x5.7x2.6x
Price / LTM Sales
37.7x31.1x3.4x
Upside (Analyst Target)
-114.8%41.1%
Fair Value Upside
Unlock−5.9%5.3%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Nov 28, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ENP Income Statement

FAQ

What Is the Entropy Neurodynamics (ENP) Stock Price Today?

The Entropy Neurodynamics stock price today is 0.037

What Stock Exchange Does Entropy Neurodynamics Trade On?

Entropy Neurodynamics is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for Entropy Neurodynamics?

The stock symbol for Entropy Neurodynamics is "ENP."

What Is the Entropy Neurodynamics Market Cap?

As of today, Entropy Neurodynamics market cap is 59.62M.

What Is Entropy Neurodynamics's Earnings Per Share (TTM)?

The Entropy Neurodynamics EPS (TTM) is -0.00.

When Is the Next Entropy Neurodynamics Earnings Date?

Entropy Neurodynamics will release its next earnings report on Jan 27, 2026.

From a Technical Analysis Perspective, Is ENP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Entropy Neurodynamics Stock Split?

Entropy Neurodynamics has split 1 times.

What is the current trading status of Entropy Neurodynamics (ENP)?

As of Jan 18, 2026, Entropy Neurodynamics (ENP) is trading at a price of 0.037, with a previous close of 0.037. The stock has fluctuated within a day range of 0.032 to 0.037, while its 52-week range spans from 0.027 to 0.046.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.